Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer
Journal of Clinical Oncology · 2024
DOI: 10.1200/jco.23.02614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2024. Verfasst von Alejandro Ríos-Hoyo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Yale Cancer Center, Yale School of Medicine, New Haven, CT. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Erb-b2 Receptor Tyrosine Kinases, Receptors, Estrogen. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Yale Cancer Center, Yale School of Medicine, New Haven, CT.
- University of Michigan, Ann Arbor, MI.
- University of California San Francisco Comprehensive Cancer Center, San Francisco, CA.
- Dallas Surgical Group, Dallas, TX.
- Scripps Health, Scripps Clinic Medical Group, San Diego, CA.
ORCID-Profile: Alejandro Ríos-Hoyo, Lajos Pusztai
Zitieren
APA
Ríos-Hoyo, A., Cobain, E., Huppert, L. A., Beitsch, P. D., Buchholz, T. A., Esserman, L., van 't Veer, L. J., Rugo, H. S., & Pusztai, L. (2024). Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.02614
Vancouver
Ríos-Hoyo A, Cobain E, Huppert LA, Beitsch PD, Buchholz TA, Esserman L, et al. Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer. Journal of Clinical Oncology. 2024. doi:10.1200/jco.23.02614
BibTeX
@article{RosHoyo2024,
author = {Ríos-Hoyo, Alejandro and Cobain, Erin and Huppert, Laura A and Beitsch, Peter D and Buchholz, Thomas A and Esserman, Laura and van 't Veer, Laura J and Rugo, Hope S and Pusztai, Lajos},
title = {Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer},
journal = {Journal of Clinical Oncology},
year = {2024},
doi = {10.1200/jco.23.02614}
}
EUVIMED